Skip to main content

Keynote webinar | Spotlight on advances in lupus

Recorded live: Tuesday 27th May, 2025

Systemic lupus erythematosus is a severe multisystem autoimmune disease that can cause damage to almost every body system. It is associated with significant morbidity and mortality, yet patient management had stagnated for much of the past century.

However, new biomarkers for early diagnosis and the development of novel targeted therapies offer hope for improving outcomes, through more personalized treatment. 

Join our experts to get up to date with these exciting and promising advances.



Log in to watch the webinar

About this webinar

Agenda

Biomarkers in lupus
Prof. Edward Vital

Novel therapies for lupus
Prof. Ronald van Vollenhoven

Faculty

Prof. Edward Vital 
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK

Prof. Ronald van Vollenhoven 
Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, the Netherlands

Learning objectives

After participating in this program, learners will have an understanding of:

  • How novel biomarkers can improve diagnosis of lupus
  • The current landscape of targeted therapies 
  • Promising emerging therapies 
  • What biomarker-driven treatment monitoring can offer

Faculty information

Prof. Edward Vital

Prof. Edward Vital is a Professor of Translational Medicine and Honorary Consultant Rheumatologist, at Leeds Teaching Hospitals NHS Trust, UK.

See full bio »

Prof. Ronald F. van Vollenhoven

Prof. Ronald F. van Vollenhoven is a Rheumatologist at the Department of Rheumatology and Clinical Immunology, Amsterdam UMC, the Netherlands.

See full bio »

Moderators

Dr. Shreeya Nanda

Senior Clinical Content Manager, Springer Medicine, London, UK

See full bio »

Dr. Jane Godsland

Clinical Director, Springer Medicine, London, UK

See full bio »

Image Credits
Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI, Prof. Edward Vital/© Edward Vital, Prof. Ronald van Vollenhoven/© Ronald van Vollenhoven, Shreeya Nanda/© Shreeya Nanda, Jane Godsland/© Jane Godsland